Reported 1 day ago
Moderna shares surged 12% to $47.53 on Tuesday, driven by investor optimism following the first U.S. death linked to H5N1 bird flu and the company's vaccine development efforts. The stock closed above its 50-day moving average, indicating bullish momentum. Key resistance levels to watch are around $57, $72, and $85, while important support levels include $44 and $37.
Source: YAHOO